The DOI matches its Crossref record; 99 of the 99 references it cites were found in a registry or an index.
Retinal Ganglion Cell Survival and Axon Regeneration after Optic Nerve Injury: Role of Inflammation and Other Factors
Open accessAbstract
The optic nerve, like most pathways in the mature central nervous system, cannot regenerate if injured, and within days, retinal ganglion cells (RGCs), the neurons that extend axons through the optic nerve, begin to die. Thus, there are few clinical options to improve vision after traumatic or ischemic optic nerve injury or in neurodegenerative diseases such as glaucoma, dominant optic neuropathy, or optic pathway gliomas. Research over the past two decades has identified several strategies to enable RGCs to regenerate axons the entire length of the optic nerve, in some cases leading to modest reinnervation of di- and mesencephalic visual relay centers. This review primarily focuses on the role of the innate immune system in improving RGC survival and axon regeneration, and its synergy with manipulations of signal transduction pathways, transcription factors, and cell-extrinsic suppressors of axon growth. Research in this field provides hope that clinically effective strategies to improve vision in patients with currently untreatable losses could become a reality in 5–10 years.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
![Figure 1 Inflammation-induced optic nerve regeneration and the role of Oncomodulin (Ocm). (a) Negative control: Absence of axon regeneration following optic nerve injury (asterisk: site of optic nerve crush injury). (b) Intraocular inflammation induced by injury to the lens (shown here) or by other means cited in the text enables retinal ganglion cells (RGCs) to regenerate axons past the injury site. (c) Intraocular inflammation is associated with a rapid infiltration of Gr-1-positive neutrophils (red) that express high levels of Ocm (green). (d) P1, a peptide antagonist of Ocm based on the N-terminus of the protein, suppresses Zymosan-induced regeneration. (e) Slow-release polymer beads containing the cAMP analog CPT-cAMP induce minimal regeneration after optic nerve injury. (f) Extensive regeneration with slow-release beads containing Ocm + CPT-cAMP [5,6,13].](https://figures.cochat.ai/paper-figures/4764c53a6f984b8cb7e19b3e1e1b4bb8/retinal-ganglion-cell-survival-and-axon-regeneration-after-optic-nerve-injury-figure-1.jpg)
![Figure 2 Macrophage-derived SDF1 complements the effects of Ocm (previous page). (a) SDF1 (red) is highly expressed in F4/80 macrophages that infiltrate the vitreous by 24 h after intraocular injection of Zymosan. (b) Among multiple trophic factors tested in dissociated adult retinal cell cultures, SDF1 is the only factor that enhances the effects of Ocm (combined with co-factors mannose and CPT-cAMP). B: Brain-derived neurotrophic factor (BDNF); C: ciliary neurotrophic factor (CNTF); G: glial cell-derived trophic factor (GDNF); L: leukemia inhibitory factor (LIF); T: tumor-necrosis factor (TNF); F: fibroblast growth factor-2; I: insulin-like growth factor 2 (IGF2). *** p < 0.001. (c) SDF1 combined with Ocm and CPT-cAMP induces similar levels of regeneration as Zymosan. (d) SDF1 alters the response of different RGC populations to PTEN deletion. aRGCs, the population that extends axons in response to Pten deletion, are identified by virtue of expressing GFP from the Kcng4 promoter. Axons arising from all RGCs, whether aRGCs or non-aRGCs, are labeled with CTB. Top row: In response to SDF1 alone, regenerating GFP-negative axons all arise from non-aRGCs. Middle row: Pten deletion alone induces regeneration primarily from aRGCs (note extensive overlap of GFP and CTB in last panel). Bottom row: Combining SDF1 and Pten deletion suppresses regeneration from aRGCs while strongly increasing overall levels of regeneration from non-αRGCs. (e) Schematic illustration showing the response of different RGC populations to various treatments. Top row: AAV2 expressing anti-Pten shRNA (AAV2-shPten) induces axon growth primarily from aRGCs (green cells). AAV2-shLuciferase virus (AAV2-shLuc) has no effects. Middle row: Either recombinant SDF1 (rSDF1) or AAV2 expressing SDF1 (AAV2-SDF1) induces moderate axon growth primarily from non-aRGCs (middle left: orange cells). When combined with Pten deletion, SDF1 induces non-aRGCs to regenerate lengthy axons but prevents aRGCs from responding to Pten deletion (middle right). Bottom row: Zymosan elevates levels of neutrophil-derived Ocm, macrophage-derived SDF1, and other factors, stimulating regeneration from both α- and non-αRGCs (bottom left); Pten deletion combined with Zymosan strongly augments outgrowth from both subtypes (bottom right) [8]. Asterisks show lesion site.](https://figures.cochat.ai/paper-figures/6eb9e5d3c80f436fad00892593e098cf/retinal-ganglion-cell-survival-and-axon-regeneration-after-optic-nerve-injury-figure-2.jpg)
![Figure 3 CNTF gene therapy induces optic nerve regeneration by augmenting inflammation and chemokine CCL5. (a) Recombinant CNTF protein (1 µg) does not induce appreciable regeneration. (b,c) Unlike a control adeno-associated protein expressing green fluorescent protein (AAV2-GFP), AAV2 expressing CNTF induces appreciable levels. (d,e) Whereas mice heterozygous for the chemokine 2 receptor (CCR2+/−) regenerate axons in response to CNTF gene therapy (d), homozygous null mice show a strongly diminished response (e). (f,g) CRISPR-Cas9 mediated deletion of the chemokine 5 receptor CCR5. Mice received intraocular injection of an adeno-associated virus expressing Cas9 driven by the synuclein-g promoter plus a second virus expressing either GFP ((f), control) or a small guide RNA directed to CCR5 (g), which nearly eliminated regeneration induced by CNTF gene therapy. (h) Recombinant CCL5 induces nearly as much regeneration as CNTF gene therapy. Asterisks indicate lesion site [22].](https://figures.cochat.ai/paper-figures/e0cdd35c128f498db44b0ac149006a04/retinal-ganglion-cell-survival-and-axon-regeneration-after-optic-nerve-injury-figure-3.jpg)
![Figure 4 Synergy between intraocular inflammation and deleting receptors for cell-extrinsic suppressors of axon growth. (a–f) Longitudinal sections through the optic nerves of wild-type mice (WT) or mice lacking all 3 isoforms of the Nogo receptor (NgR123−/−) or of NgR1 and 3 plus PTPs, a receptor that mediates inhibitory effects of chondroitin sulfate proteoglycans (CSPGs). As indicated, mice either underwent optic nerve injury alone or with intraocular inflammation following intraocular injection of zymosan. (a’–f’) Regions of optic nerves shown at greater magnification in the corresponding panels below. Note the dramatic increase in regeneration when combining intraocular inflammation with deletion of receptors for the inhibitory molecules associated with myelin and CSPGs. Asterisks show lesion site [40].](https://figures.cochat.ai/paper-figures/d1917610a14243c2a7d14d89634d4b11/retinal-ganglion-cell-survival-and-axon-regeneration-after-optic-nerve-injury-figure-4.jpg)

![Figure 6 Phagocytic microglia/monocytes alter the local environment of the injury site and modulate axon regeneration. (a) Single confocal planes with orthogonal views of myelin basic protein (MBP) debris inside CR3+ cells. Images are from 0.2 and 0.4 mm distal to the injury site at 14 DPI [44]. (b) CR3+ microglia and monocytes expand within the site of injury (dotted line) from 1 to 5 days after crush, resulting in a progressive clearance of MBP from the distal optic nerve, allowing for uninhibited axon regeneration [44]. (c) Treatment with CSF1R inhibitor, PLX5622 (PLX) results in efficient clearance of IBA1+ microglia from the retina, which is maintained by 14 days after ONI (14d post-ONI). (d) Microglia deletion enhances the number of GAP43+ (green) axons regenerating past the crush site (dotted line). Right: Quantitation of regenerating axons 0.5 mm distal to the injury site (☐); mean ± s.e.m, n = optic nerves, **, p ≤ 0.01 by t-test [44].](https://figures.cochat.ai/paper-figures/b623aa5f00bd493d9c11303b6062a647/retinal-ganglion-cell-survival-and-axon-regeneration-after-optic-nerve-injury-figure-6.jpg)
![Figure 7 Full-length optic nerve regeneration. (a) Intraocular inflammation combined with CPT-cAMP and virally mediated PTEN deletion enables RGCs to regenerate axons the full length of the optic nerve in 8–10 weeks. Axons are labeled by intraocular injection of cholera toxin B fragment (CTB, red). (b) Control optic nerve in case treated with intraocular Zymosan and a control virus. (c–e) Enlargements of area within rectangle show overlap in immunostaining fibers for CTB (c, red) and the growth-associated protein GAP43 (d, green). Asterisks show lesion site [79].](https://figures.cochat.ai/paper-figures/0323541174b248d3826a2f6931b46c1c/retinal-ganglion-cell-survival-and-axon-regeneration-after-optic-nerve-injury-figure-7.jpg)
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“Research has shown improved RGC survival when the role of these cell types was promoted.31,32”
From Retinal organoid chip: engineering a physiomimetic oxygen gradient for optimizing long term culture of human retinal organoids (2025) · cites this paper as [32]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Neurotoxic reactive astrocytes are induced by activated microglia
Liddelow, S. A., Guttenplan, K. A., Clarke, L. E., Bennett, F. C., Bohlen, C. J., Schirmer, L., Bennett, M. L., Münch, A. E., Chung, W.-S., Peterson, T. C., et al. (2017) · Nature · doi:10.1038/nature21029 · Cited by 7,971
Microglia Sculpt Postnatal Neural Circuits in an Activity and Complement-Dependent Manner
Schafer, D. P., Lehrman, E. K., Kautzman, A. G., Koyama, R., Mardinly, A. R., Yamasaki, R., Ransohoff, R. M., Greenberg, M. E., Barres, B. A., & Stevens, B. (2012) · Neuron · doi:10.1016/j.neuron.2012.03.026 · Cited by 4,089 · cited 2×
“icroglia are concentrated in the inner and outer plexifor layers of the retina and throughout the optic nerve, ith long ra ified processes that interact ith and surveil the neural environ ent and reg late retinal synapses [45,46].”
BackgroundThe Classical Complement Cascade Mediates CNS Synapse Elimination
Stevens, B., Allen, N. J., Vazquez, L. E., Howell, G. R., Christopherson, K. S., Nouri, N., Micheva, K. D., Mehalow, A. K., Huberman, A. D., Stafford, B., et al. (2007) · Cell · doi:10.1016/j.cell.2007.10.036 · Cited by 3,313 · cited 2×
“icroglia are concentrated in the inner and outer plexifor layers of the retina and throughout the optic nerve, ith long ra ified processes that interact ith and surveil the neural environ ent and reg late retinal synapses [45,46].”
BackgroundGenomic analysis of reactive astrogliosis
Zamanian, J. L., Xu, L., Foo, L. C., Nouri, N., Zhou, L., Giffard, R. G., & Barres, B. A. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.6221-11.2012 · Cited by 2,404
Promoting Axon Regeneration in the Adult CNS by Modulation of the PTEN/mTOR Pathway
Park, K. K., Liu, K., Hu, Y., Smith, P. D., Wang, C., Cai, B., Xu, B., Connolly, L., Kramvis, I., Sahin, M., et al. (2008) · Science · doi:10.1126/science.1161566 · Cited by 1,686 · cited 2×
“mTOR (mammalian target of rapamycin), a central regulator of cell growth, is an important downstream target of PI3 kinase, and disinhibiting mTOR or upregulating a proximate upstream regulator (cRheb1) also promotes optic nerve regeneration, albeit to a lesser extent than Pten deletion [78].”
BackgroundDebris clearance by microglia: an essential link between degeneration and regeneration
Neumann, H., Kotter, M. R., & Franklin, R. J. M. (2008) · Brain · doi:10.1093/brain/awn109 · Cited by 1,111 · cited 1×
“These latter effects are mediated through complement pathway-induced activation of resident microglia and/or by increasing the infiltration of CR3-expressing monocytes/macrophages at the lesion site [44], where these cells phagocytose myelin debris (Figure 6a,b) that would otherwise inhibit axon regeneration [36,76,77…”
BackgroundThe Biology of Regeneration Failure and Success After Spinal Cord Injury
Tran, A. P., Warren, P. M., & Silver, J. (2018) · Physiological Reviews · doi:10.1152/physrev.00017.2017 · Cited by 884
Reprogramming to recover youthful epigenetic information and restore vision
Lu, Y., Brommer, B., Tian, X., Krishnan, A., Meer, M., Wang, C., Vera, D. L., Zeng, Q., Yu, D., Bonkowski, M. S., et al. (2020) · Nature · doi:10.1038/s41586-020-2975-4 · Cited by 820
Sustained axon regeneration induced by co-deletion of PTEN and SOCS3
Sun, F., Park, K. K., Belin, S., Wang, D., Lu, T., Chen, G., Zhang, K., Yeung, C., Feng, G., Yankner, B. A., et al. (2011) · Nature · doi:10.1038/nature10594 · Cited by 754 · cited 1×
“Combining double deletion of Pten and Socs3 with CNTF treatment allows many axons to regenerate the full extent of the optic nerve and into the brain, albeit into largely inappropriate areas [81,82].”
BackgroundKLF Family Members Regulate Intrinsic Axon Regeneration Ability
Moore, D. L., Blackmore, M. G., Hu, Y., Kaestner, K. H., Bixby, J. L., Lemmon, V. P., & Goldberg, J. L. (2009) · Science · doi:10.1126/science.1175737 · Cited by 714 · cited 3×
“Various members of the Krüppel-like family (KLF) of transcription factors regulate axon outgrowth in RGCs and other neurons [20,84,85].”
Research works printed but not linked: 2
- Xie, L., Yin, Y., Peterson, S.L., Jayakar, S., Shi, C., Lenfers Turnes, B., Zhang, Z., Oses-Prieto, J., Li, J., and Burlingame, A. (, January 12–16). The atypical receptor-ligand pair Ocm-R/oncomodulin enables axon regeneration in the central and peripheral nervous systems. Proceedings of the Society for Neuroscience, San Diego, CA, USA.
- Feng, Q., Wong, K.A., Peterson, S.L., and Benowitz, L. (May, January 28). Harnessing neuroinflammation to promote axon regeneration after optic nerve injury. Proceedings of the Association for Research in Vision and Ophthalmology Annual Meeting, Vancouver, BC, Canada.
Cited by
Soucy, J. R., Aguzzi, E. A., Cho, J. Y., Gilhooley, M. J., Keuthan, C. J., Luo, Z., Monavarfeshani, A., Saleem, M. A., Wang, X., Wohlschlegel, J., et al. (2023) · Molecular Neurodegeneration · doi:10.1186/s13024-023-00655-y · Cited by 89
Self-citationOxidative Stress: A Suitable Therapeutic Target for Optic Nerve Diseases?
Buonfiglio, F., Böhm, E. W., Pfeiffer, N., & Gericke, A. (2023) · Antioxidants · doi:10.3390/antiox12071465 · Cited by 77
“Exploring these avenues may also offer new therapeutic perspectives for other neurodegenerative diseases, including optic neuropathies [69].”
BackgroundCircular RNA-based therapy provides sustained and robust neuroprotection for retinal ganglion cells
Jiang, W., Xiao, D., Wu, C., Yang, J., Peng, X., Chen, L., Zhang, J., Zha, G.-F., Li, W., Ju, R., et al. (2024) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2024.102258 · Cited by 44
The concept of gene therapy for glaucoma: the dream that has not come true yet
Sulak, R., Liu, X., & Smedowski, A. (2024) · Neural Regeneration Research · doi:10.4103/1673-5374.375319 · Cited by 40
“Oncomodulin is a calcium-binding protein belonging to the parvalbumin family that is derived from macrophages and released into the vitreous and retina, and can promote optic nerve regeneration after insult (de Lima et al., 2012a, b; Williams et al., 2020; Wong and Benowitz, 2022).”
BackgroundCalcium-Associated Proteins in Neuroregeneration
Lisek, M., Tomczak, J., Boczek, T., & Żylińska, L. (2024) · Biomolecules · doi:10.3390/biom14020183 · Cited by 38
“The combination of OCM, SDF1, and a cAMP analog not only replicates but also surpasses the effects of intraocular inflammation on optic nerve regeneration, presenting a promising avenue for enhancing regenerative outcomes [131].”
Background
Metadata
- Authors
- Wong, K. A., & Benowitz, L. I.
- Affiliations
- Boston Children's Hospital (US)
- Corresponding author
- Wong, Kimberly A.
- Benowitz, Larry I.
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2022-09-05
- Volume
- 23
- Issue
- 17
- Pages
- 10179
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC9456227
- OpenAlex
- W4294733128
- Cited by
- 66
- References
- 99
- Citations by year
- 2026: 14 · 2025: 15 · 2024: 19 · 2023: 18
- FWCI
- 1.85
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Gilbert Family Foundation Vision Restoration Initiative (HD018655)
- Miriam and Sheldon G. Adelson Medical Research Foundation (HD018655)
- NIH Intellectual and Developmental Disabilities Research Centers Imaging Core of Boston Children’s Hospital (HD018655)
- BrightFocus National Glaucoma Research Postdoctoral Award (HD018655)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Nerve injury and regeneration
- Health Sciences › Medicine › Ophthalmology › Glaucoma and retinal disorders
- Life Sciences › Neuroscience › Developmental Neuroscience › Neurogenesis and neuroplasticity mechanisms
- Keywords
- retinal ganglion cells, optic nerve injury, axon regeneration, retinal ganglion cell survival, inflammation, innate immune system, glaucoma, optic neuropathy, optic pathway glioma, signaling pathways, transcription factors, vision loss
- MeSH terms
- Axons, Cell Survival, Humans, Inflammation, Nerve Regeneration, Retinal Ganglion Cells, Optic Nerve Injuries
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Retinal Ganglion Cell Survival and Axon Regeneration after Optic Nerve Injury: Role of Inflammation and Other Factors. https://app.cochat.ai/papers/10.3390/ijms231710179
- The paper
- Wong, K. A., & Benowitz, L. I. (2022). Retinal Ganglion Cell Survival and Axon Regeneration after Optic Nerve Injury: Role of Inflammation and Other Factors. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms231710179
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.